日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model

基于药代动力学/药效学模型确定新型TGF-β抑制剂LY2157299一水合物的治疗窗口

Gueorguieva, Ivelina; Cleverly, Ann L; Stauber, Anja; Sada Pillay, N; Rodon, Jordi A; Miles, Colin P; Yingling, Jonathan M; Lahn, Michael M

Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth

转化生长因子β(TGF-β)受体I激酶抑制剂对前列腺癌骨生长的影响

Wan, Xinhai; Li, Zhi-Gang; Yingling, Jonathan M; Yang, Jun; Starbuck, Michael W; Ravoori, Murali K; Kundra, Vikas; Vazquez, Elba; Navone, Nora M

Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761

长期使用 LY2109761 抑制 TβRI/II 激酶后,表达肿瘤侵袭性标志物的耐药性癌的生长

Connolly, Erin C; Saunier, Elise F; Quigley, David; Luu, Minh Thu; De Sapio, Angela; Hann, Byron; Yingling, Jonathan M; Akhurst, Rosemary J

Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.

靶向转化生长因子-β通路可抑制人类基底样乳腺癌转移

Ganapathy Vidya, Ge Rongrong, Grazioli Alison, Xie Wen, Banach-Petrosky Whitney, Kang Yibin, Lonning Scott, McPherson John, Yingling Jonathan M, Biswas Swati, Mundy Gregory R, Reiss Michael

Smad7 regulates the adult neural stem/progenitor cell pool in a transforming growth factor beta- and bone morphogenetic protein-independent manner

Smad7以一种不依赖于转化生长因子β和骨形态发生蛋白的方式调控成体神经干/祖细胞库。

Krampert, Monika; Chirasani, Sridhar Reddy; Wachs, Frank-Peter; Aigner, Robert; Bogdahn, Ulrich; Yingling, Jonathan M; Heldin, Carl-Henrik; Aigner, Ludwig; Heuchel, Rainer